Back to Studies

P1086 / Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen

A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Infected Pregnant Women

Study Status

Concluded

DAIDS Number

10835

IND Number

BB 14147

Study Co-Chair

Study Vice-Chair

NICHD Medical Officer

Data Manager

Field Representative

Immunologist

Investigator

Laboratory Technologist

Protocol Pharmacist

Senior Statistician

Statistician

Virologist

Westat Representative

Abstracts

H1N1 Influenza Vaccination does not appear to alter HIV-1 DNA Reservoirs

Conference

PAS 2015 Annual Meeting

Study

P1086

Authors

Christen E Salyer, Thor A Wagner, Hannah C Huang, Kelly Richardson, Adriana Weinberg, Sharon Nachman, Lisa M Frenkel

Safety of an Inactivated Influenza A (H1N1) Monovalent Vaccine (H1N1 Vaccine) in HIV-1 Infected Pregnant Women

Conference

17th Conference on Retroviruses & Opportunistic Infections

Study

P1086

Authors

Sharon Appelbaum Nachman, Adriana Weinberg, Petronella Muresan, Mark J. Abzug, Ruth Ebiasah, Elizabeth Petzold, Barbara E. Heckman, Heather D. Watts, Judi A. Miller, Myron Levin

Safety and Immunogenicity of Two Doses of Monovalent Pandemic H1N1 (pH1N1) Influenza Vaccine in HIV-Infected Pregnant Women

Conference

48th Annual Meeting of Infectious Diseases Society of Amercia

Study

P1086

Manuscripts